INNOPRAN XL Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Innopran Xl, and what generic alternatives are available?

Innopran Xl is a drug marketed by Ani Pharms and is included in one NDA.

The generic ingredient in INNOPRAN XL is propranolol hydrochloride. There are twenty-two drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the propranolol hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Innopran Xl

A generic version of INNOPRAN XL was approved as propranolol hydrochloride by INNOGENIX on October 22^nd, 1985.

Try a Trial

Summary for INNOPRAN XL

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	157
Clinical Trials:	4
Patent Applications:	3,873
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for INNOPRAN XL
What excipients (inactive ingredients) are in INNOPRAN XL?	INNOPRAN XL excipients list
DailyMed Link:	INNOPRAN XL at DailyMed

Drug patent expirations by year for INNOPRAN XL

Recent Clinical Trials for INNOPRAN XL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Missouri-Columbia	Early Phase 1
United States Department of Defense	Early Phase 1
University of North Carolina, Chapel Hill	Phase 2

See all INNOPRAN XL clinical trials

Pharmacology for INNOPRAN XL

Drug Class	beta-Adrenergic Blocker
Mechanism of Action	Adrenergic beta-Antagonists

Anatomical Therapeutic Chemical (ATC) Classes for INNOPRAN XL

C07AA	Beta blocking agents, non-selective
C07A	BETA BLOCKING AGENTS
C07	BETA BLOCKING AGENTS
C	Cardiovascular system

US Patents and Regulatory Information for INNOPRAN XL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ani Pharms	INNOPRAN XL	propranolol hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	021438-001	Mar 12, 2003	BX	RX	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Ani Pharms	INNOPRAN XL	propranolol hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	021438-002	Mar 12, 2003	BX	RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for INNOPRAN XL

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ani Pharms	INNOPRAN XL	propranolol hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	021438-001	Mar 12, 2003	⤷ Try a Trial	⤷ Try a Trial
Ani Pharms	INNOPRAN XL	propranolol hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	021438-002	Mar 12, 2003	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for INNOPRAN XL

See the table below for patents covering INNOPRAN XL around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Japan	2005508922		⤷ Try a Trial
European Patent Office	1432411	FORMES POSOLIGIQUES MULTIPARTICULAIRES A LIBERATION PROGRAMMEE ET PROLONGEE DE PROPANOLOL (TIMED, SUSTAINED RELEASE MULTI-PARTICULATE DOSAGE FORMS OF PROPRANOLOL)	⤷ Try a Trial
Spain	2333306		⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for INNOPRAN XL

Recent Clinical Trials for INNOPRAN XL

Pharmacology for INNOPRAN XL

Anatomical Therapeutic Chemical (ATC) Classes for INNOPRAN XL

Make Better Decisions: Try a trial or see plans & pricing